Search - tctmd.com

Displaying 61 - 80 of 186

Sort: Relevancy | Date

News Conference News TCT 2020

Shorter DAPT Succeeds in Xience-Treated Patients at High Bleeding Risk

Caitlin E. Cox

October 15, 2020

News Conference News TCT 2020

Valve Disease Plus COVID-19 Often a Lethal Combination, Registry Shows

Caitlin E. Cox

October 14, 2020

News Conference News TCT 2020

Interventionalists, Including PERTs, Grapple With VTE Risks of COVID-19

Michael O'Riordan

October 14, 2020

News Conference News TCT 2020

No Reperfusion Benefit From Crushed Prasugrel Prior to PCI: COMPARE CRUSH

L.A. McKeown

October 14, 2020

News Conference News TCT 2019

Watchman Adverse Events: Analysis Digs Into What’s Been Reported to the FDA

Todd Neale

October 04, 2019

Off Script: A (Not So) Brief History of Aspirin’s Rise and Fall

News Opinion Off Script TCT 2019

Off Script: The TWILIGHT of Aspirin? A Brief History of ASA’s Rise and Fall

Kwan S. Lee

September 29, 2019

Presentation TCT 2019

Mitral Valvuloplasty State of the Art: Indications, Devices, Technique, and Outcomes

Presenter: Habib Gamra

September 28, 2019

Presentation TCT 2019

Nonrheumatic MAC-Related Mitral Stenosis and Balloon Valvuloplasty

Presenter: Igor Palacios

September 28, 2019

Presentation TCT 2019

MAC Types and Clinical Implications

Presenter: Philipp Blanke

September 28, 2019

Presentation TCT 2019

What Can We Learn From MRI About FMR Proportionality?

Presenter: Michael Salerno

September 28, 2019

Presentation TCT 2019

Advantages and Limitations of MRI for MR Assessment at Baseline and Post-MitraClip

Presenter: Joao Cavalcante

September 28, 2019

Presentation TCT 2019

Nonesophageal Mitral Echo Imaging

Presenter: Stephen Little

September 28, 2019

Presentation TCT 2019

Advanced Mitral Imaging, Intraprocedural Guidance, and Image Fusion Technologies

Presenter: Rhonda Miyasaka

September 28, 2019

Presentation TCT 2019

State of the Art: FMR Severity Assessment by Quantitative Echo

Presenter: Linda Gillam

September 28, 2019

Presentation TCT 2019

State of the Art: DMR Severity Assessment by Quantitative Echo

Presenter: Burkhart Mackensen

September 28, 2019

Presentation TCT 2019

Transcatheter Mitral Valve Repair and Replacement Clinical Trial Designs After COAPT and MITRA-FR

Presenter: Gregg Stone

September 28, 2019

Presentation TCT 2019

Antiplatelet and Anticoagulation After TMVR and TAVR: Considerations and Recommendations

Presenter: Robert Bonow

September 28, 2019

Presentation TCT 2019

Combination Valve Treatments (MR and TR/MR and AS): Rationale, Sequence, and Results

Presenter: Georg Nickenig

September 28, 2019

News Conference News TCT 2019

Oral Anticoagulation After TAVR Doesn’t Reduce Ischemic Cerebral Lesions: AUREA

Michael O'Riordan

September 28, 2019

Presentation TCT 2019

A Randomized Trial of Short-Course Dual Antiplatelet Therapy vs. Oral Anticoagulation to Prevent Cerebral Embolism After Transcatheter Aortic Valve Implantation

Presenter: Victor Alfonso Dias

September 28, 2019

Advertisement

Shorter DAPT Succeeds in Xience-Treated Patients at High Bleeding Risk

Valve Disease Plus COVID-19 Often a Lethal Combination, Registry Shows

Interventionalists, Including PERTs, Grapple With VTE Risks of COVID-19

No Reperfusion Benefit From Crushed Prasugrel Prior to PCI: COMPARE CRUSH

Watchman Adverse Events: Analysis Digs Into What’s Been Reported to the FDA

Off Script: The TWILIGHT of Aspirin? A Brief History of ASA’s Rise and Fall

Mitral Valvuloplasty State of the Art: Indications, Devices, Technique, and Outcomes

Nonrheumatic MAC-Related Mitral Stenosis and Balloon Valvuloplasty

MAC Types and Clinical Implications

What Can We Learn From MRI About FMR Proportionality?

Advantages and Limitations of MRI for MR Assessment at Baseline and Post-MitraClip

Nonesophageal Mitral Echo Imaging

Advanced Mitral Imaging, Intraprocedural Guidance, and Image Fusion Technologies

State of the Art: FMR Severity Assessment by Quantitative Echo

State of the Art: DMR Severity Assessment by Quantitative Echo

Transcatheter Mitral Valve Repair and Replacement Clinical Trial Designs After COAPT and MITRA-FR

Antiplatelet and Anticoagulation After TMVR and TAVR: Considerations and Recommendations

Combination Valve Treatments (MR and TR/MR and AS): Rationale, Sequence, and Results

Oral Anticoagulation After TAVR Doesn’t Reduce Ischemic Cerebral Lesions: AUREA

A Randomized Trial of Short-Course Dual Antiplatelet Therapy vs. Oral Anticoagulation to Prevent Cerebral Embolism After Transcatheter Aortic Valve Implantation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content